Neurological Genetics tests in Dubai & UAE

Compare available Neurological Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

2,000.00–3,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Neurological Genetics test prices

Showing 31–45 of 71 matching tests.

Neurological Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5830 FUS Gene Essential Tremor Type 4 Genetic Test This test identifies pathogenic variants within the FUS gene associated with hereditary essential tremor type 4.	Peripheral Whole Blood	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FUS gene", "Copy Number Variants (CNVs) in the FUS gene"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medications without consulting your physician"] Indications ["Clinical suspicion of hereditary essential tremor type 4", "Family history suggestive of FUS-related tremor"] Measurement technique Confirm with laboratory Codes LOINC: 101388-5 ICD-10: G25.0 Clinical summary This test identifies pathogenic variants within the FUS gene associated with hereditary essential tremor type 4.
TEST-4241 GABRA1 Gene (Early Infantile Epileptic Encephalopathy Type 19) Genetic Test This test identifies pathogenic variants in the GABRA1 gene associated with Early Infantile Epileptic Encephalopathy Type 19 (EIEE19).	Whole Blood (EDTA) or FTA Card	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GABRA1 gene", "Copy Number Variations (CNV) in the GABRA1 gene"] Parameters [] Preparation ["Genetic counselling & pedigree chart (included in service)", "Avoid collection if active febrile illness within 48 hours"] Indications ["Suspected Early Infantile Epileptic Encephalopathy Type 19 (EIEE19)", "Family history of GABRA1-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 21614-4 ICD-10: G40.4 Clinical summary This test identifies pathogenic variants in the GABRA1 gene associated with Early Infantile Epileptic Encephalopathy Type 19 (EIEE19).
TEST-4514 GABRG2 Gene Generalized Epilepsy with Febrile Seizures Plus Type 3 Genetic Test This test identifies pathogenic variants in the GABRG2 gene associated with Generalized Epilepsy with Febrile Seizures Plus type 3 (GEFS+3).	Whole blood (EDTA tube), extracted DNA (≥1 µg), or FTA card blood spot	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GABRG2 gene variants", "Pathogenic mutations"] Parameters [] Preparation ["No fasting or dietary preparation required", "Continue all regular medications as directed"] Indications ["Suspected diagnosis of GEFS+3", "Family history of GEFS+3", "Need for accurate recurrence risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 94231-1 ICD-10: G40.3 Clinical summary This test identifies pathogenic variants in the GABRG2 gene associated with Generalized Epilepsy with Febrile Seizures Plus type 3 (GEFS+3).
TEST-4334 GABRG2 Gene Genetic Test (Childhood Absence Epilepsy Type 2) This test identifies pathogenic variants in the GABRG2 gene, which are causally linked to Childhood Absence Epilepsy Type 2 (CAE2).	Whole Blood (EDTA tube, 3–5 mL), Extracted DNA (min 1 µg), Dried Blood Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GABRG2 gene sequence", "Single nucleotide variants", "Small insertions/deletions", "Copy number variations"] Parameters [{"name": "Diagnostic Sensitivity", "reference_range": "99.9%"}, {"name": "Mean Coverage Depth", "reference_range": ">100x"}] Preparation ["No fasting required", "No medication adjustment required"] Indications ["Diagnosis of Childhood Absence Epilepsy Type 2", "Guiding antiepileptic drug selection", "Prognostic counselling", "Family planning and cascade testing"] Measurement technique Confirm with laboratory Codes LOINC: 21623-1 ICD-10: G40.3 Clinical summary This test identifies pathogenic variants in the GABRG2 gene, which are causally linked to Childhood Absence Epilepsy Type 2 (CAE2).
TEST-5262 GFER Gene-Related Mitochondrial Progressive Myopathy with Congenital Cataract, Hearing Loss, and Developmental Delay Test This test provides definitive molecular confirmation for GFER-related mitochondrial myopathy with congenital cataract, sensorineural hearing loss, and developmental delay.	Whole Blood (EDTA tube), Extracted DNA (minimum 1 µg at ≥50 ng/µL), or One Drop of Blood on FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GFER gene", "SNVs", "Indels", "Copy number variants"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication"] Indications ["Suspected GFER-related mitochondrial myopathy", "Congenital cataract with hearing loss and developmental delay", "Family history of GFER-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 86204-6 ICD-10: G71.8, H90.5, Q12.0, Z15.89 Clinical summary This test provides definitive molecular confirmation for GFER-related mitochondrial myopathy with congenital cataract, sensorineural hearing loss, and developmental delay.
TEST-3888 GRM7 Genetic Test (NGS DNA Sequencing) for Autism Spectrum, Hyperactivity, and Bipolar Disorder This test evaluates the GRM7 gene for pathogenic variants associated with neurodevelopmental disorders like ASD, ADHD, and bipolar disorder.	Peripheral Whole Blood	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GRM7 gene", "Copy Number Variations (CNVs) in the GRM7 gene"] Parameters [] Preparation ["No fasting required", "No medication adjustments required", "All current therapies must be disclosed during genetic counselling"] Indications ["Personal or family history of ASD, ADHD, or bipolar disorder", "Early-onset symptoms of these conditions", "Multiple affected family members"] Measurement technique Confirm with laboratory Codes LOINC: 104197-7 ICD-10: Z13.89 Clinical summary This test evaluates the GRM7 gene for pathogenic variants associated with neurodevelopmental disorders like ASD, ADHD, and bipolar disorder.
TEST-4329 GUF1 Gene Early Infantile Epileptic Encephalopathy Type 40 Genetic Test This test identifies pathogenic variants in the GUF1 gene associated with early infantile epileptic encephalopathy type 40.	Whole blood (EDTA), Saliva, or Buccal swab	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GUF1 gene variants", "Mitochondrial translation factor function"] Parameters [] Preparation ["Genetic counselling session required before sample collection"] Indications ["Diagnosis of early infantile epileptic encephalopathy type 40", "Identification of GUF1 gene variants"] Measurement technique Confirm with laboratory Codes LOINC: 81307-1 ICD-10: G40.4 Clinical summary This test identifies pathogenic variants in the GUF1 gene associated with early infantile epileptic encephalopathy type 40.
TEST-4910 HSD17B10 Gene (X‑Linked Mental Retardation Type 17 / HSD10 Disease) Genetic Test This genetic test identifies pathogenic mutations in the HSD17B10 gene associated with X-linked mental retardation type 17 (MRX17) and HSD10 mitochondrial disease.	Peripheral whole blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the HSD17B10 gene", "Single nucleotide variants (SNVs)", "Small insertions or deletions (indels)"] Parameters [] Preparation ["No specific fasting required.", "No special medication or diet restrictions."] Indications ["Suspected X-linked mental retardation type 17 (MRX17)", "Suspected HSD10 mitochondrial disease", "Individuals with clinical features suggestive of the disorder"] Measurement technique Confirm with laboratory Codes LOINC: 81257-3 ICD-10: F78 Clinical summary This genetic test identifies pathogenic mutations in the HSD17B10 gene associated with X-linked mental retardation type 17 (MRX17) and HSD10 mitochondrial disease.
TEST-4074 HSPB1 Gene CMT2F Genetic Test This genetic test evaluates the HSPB1 gene for pathogenic variants associated with Charcot-Marie-Tooth disease type 2F (CMT2F), a hereditary neuropathy.	Whole Blood, FTA Card (Dried Blood Spot), or Extracted DNA	3–4 Weeks (14–21 Business Days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the HSPB1 gene", "Missense, nonsense, splice-site, and small indel variants"] Parameters [] Preparation [] Indications ["Clinical suspicion of axonal CMT2F", "Progressive distal weakness", "Family history of hereditary neuropathy"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: G60.0 Clinical summary This genetic test evaluates the HSPB1 gene for pathogenic variants associated with Charcot-Marie-Tooth disease type 2F (CMT2F), a hereditary neuropathy.
TEST-4269 KCNA2 Gene Sequencing for Early Infantile Epileptic Encephalopathy Type 32 (EIEE32) Test This test detects pathogenic variants in the KCNA2 gene associated with Early Infantile Epileptic Encephalopathy Type 32 (EIEE32).	Peripheral whole blood, extracted DNA, or dried blood spot on FTA card	3 – 4 Weeks (guaranteed)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the KCNA2 gene", "Single nucleotide variants", "Indels", "Copy number changes"] Parameters [] Preparation [] Indications ["Infants with refractory seizures and developmental delay", "Suspected Early Infantile Epileptic Encephalopathy Type 32 (EIEE32)"] Measurement technique Confirm with laboratory Codes LOINC: 21656-9 ICD-10: G40.4 Clinical summary This test detects pathogenic variants in the KCNA2 gene associated with Early Infantile Epileptic Encephalopathy Type 32 (EIEE32).
TEST-5919 KCNJ18 Gene Thyrotoxic Periodic Paralysis Type 2 Genetic Test (NGS) This genetic test identifies pathogenic variants in the KCNJ18 gene associated with Thyrotoxic Periodic Paralysis Type 2.	Whole blood (EDTA), extracted DNA, or finger-prick dried blood spot on FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the KCNJ18 gene"] Parameters [] Preparation ["Genetic counselling session required before sample collection", "Comprehensive pedigree chart of affected family members needed"] Indications ["Suspected Thyrotoxic Periodic Paralysis Type 2", "Family history of TPP2", "Recurrent episodes of paralysis linked to thyroid dysfunction"] Measurement technique Confirm with laboratory Codes LOINC: 94237-6 ICD-10: G72.3 Clinical summary This genetic test identifies pathogenic variants in the KCNJ18 gene associated with Thyrotoxic Periodic Paralysis Type 2.
TEST-5588 KCNQ3 Gene Seizures, Benign Neonatal, Type 2 Genetic Test This test evaluates the KCNQ3 gene for mutations associated with benign familial neonatal seizures type 2 (BFNS2).	Whole blood, extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["KCNQ3 gene sequence", "Coding exons and splice-site regions of KCNQ3 gene"] Parameters [] Preparation ["No special preparation or fasting is needed for the infant", "A pre-test genetic counselling session is required"] Indications ["Newborns with suspected benign familial neonatal seizures type 2 (BFNS2)", "Differential diagnosis of neonatal seizures"] Measurement technique Confirm with laboratory Codes LOINC: 81319-0 ICD-10: G40.3 Clinical summary This test evaluates the KCNQ3 gene for mutations associated with benign familial neonatal seizures type 2 (BFNS2).
TEST-4232 KCNT1 Gene Early Infantile Epileptic Encephalopathy Type 14 (EIEE14) Genetic Test This genetic test screens for mutations in the KCNT1 gene responsible for Early Infantile Epileptic Encephalopathy Type 14.	Whole blood, extracted DNA, or one drop blood on FTA card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["KCNT1 gene pathogenic variants", "Copy number variations in KCNT1"] Parameters [] Preparation [] Indications ["Suspected diagnosis of EIEE14", "Neonatal-onset developmental and epileptic disorder"] Measurement technique Confirm with laboratory Codes LOINC: 93014-4 ICD-10: G40.4 Clinical summary This genetic test screens for mutations in the KCNT1 gene responsible for Early Infantile Epileptic Encephalopathy Type 14.
TEST-4669 KIAA0586 Gene (Joubert Syndrome Type 23) Next-Generation Sequencing (Genetic Test This genetic test identifies pathogenic variants in the KIAA0586 gene associated with Joubert syndrome type 23.	Whole Blood, Extracted DNA, or One-drop Blood on FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in KIAA0586 gene", "Full gene coverage (exons, splice sites)"] Parameters [] Preparation ["Mandatory pre-test genetic counselling session"] Indications ["Diagnosis confirmation for Joubert syndrome type 23", "Carrier screening", "Prenatal planning"] Measurement technique Confirm with laboratory Codes LOINC: 50396-9 ICD-10: Q04.3 Clinical summary This genetic test identifies pathogenic variants in the KIAA0586 gene associated with Joubert syndrome type 23.
TEST-5621 L1CAM (SPG1) Gene Sequencing Test This test detects pathogenic variants in the L1CAM gene associated with X-linked hereditary spastic paraplegia type 1 (SPG1).	Whole Blood (3 ml EDTA) or Dried Blood Spot (FTA card)	3 – 4 Weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the L1CAM gene"] Parameters [] Preparation ["Mandatory genetic counselling session prior to sample collection", "No fasting required"] Indications ["Suspected diagnosis of X-linked hereditary spastic paraplegia type 1 (SPG1)", "Family history of SPG1", "Genetic counselling for families with SPG1"] Measurement technique Confirm with laboratory Codes LOINC: 101182-8 ICD-10: G11.4, Z13.71, Z15.89 Clinical summary This test detects pathogenic variants in the L1CAM gene associated with X-linked hereditary spastic paraplegia type 1 (SPG1).

Category overview

Neurological Genetics: overview

Securing a deep, fundamental understanding of your family's neurological blueprint allows for proactive, highly informed medical decisions that protect your long-term cognitive and motor vitality. As the core of our advanced neuro-diagnostic laboratory services, the Neurological Genetics department utilizes state-of-the-art sequencing and targeted DNA analysis to uncover the precise genetic mutations driving rare brain, spinal cord, and peripheral nerve diseases. By leveraging advanced molecular technology, this expansive profiling helps establish an absolute diagnosis for elusive conditions, safely guiding your healthcare provider in tailoring highly personalized precision medicine, supportive therapies, and proactive family planning. Trusted for clinical rigor across premier diagnostic labs in the UAE, DNA Labs guarantees strict patient confidentiality, exceptional analytical accuracy, and incredibly prompt turnaround times. Take an empowered step toward targeted neurological support—schedule your neurological genetics testing in UAE, coordinate a seamless clinic or home sample collection, or connect with our specialized specialists.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.